Skip to main content
. Author manuscript; available in PMC: 2018 Nov 22.
Published in final edited form as: Biol Psychiatry. 2018 May 3;84(8):555–562. doi: 10.1016/j.biopsych.2018.04.013

Figure 5.

Figure 5.

FG-3019, an anti–connective tissue growth factor antibody, decreased depression-like behavior. (A) Acute administration of FG-3019 decreased time spent immobile and increased time spent swimming in the forced swim test. n = 11–12 per group. All values are mean ± SEM. *p < .05. (B) Chronic administration of FG-3019 decreased time spent immobile and increased time spent climbing in the forced swim test. n = 7–8 per group. All values are mean 6 SEM. ***p < .001.